Alinity c Lactate Dehydrogenase2 (LDH2)

Lactate dehydrogenase (LDH) - tumor marker · class III · Until 27/07/2036

Registration no.
80146502432
Process no.
25351099684202687
Status
Until 27/07/2036
Device type
Lactate dehydrogenase (LDH) - tumor marker (LACTATO DESIDROGENASE (LDH) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER)
Risk class
III
Registration holder
ABBOTT LABORATORIOS DO BRASIL LTDA CNPJ 56.998.701/0001-16 · 2,467 registrations
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION · Ireland
Published
27/07/2026
Valid until
27/07/2036
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other lactate dehydrogenase (ldh) - tumor marker registrations (4 in total, see all)

ProductClass HolderPublishedStatus
LDH (IFCC)
80254180494
III PHADIA DIAGNOSTICOS LTDA 05/10/2026 Until 05/10/2036
Família Lactate Dehydrogenase acc. to IFCC ver.2
10287411812
III ROCHE DIAGNÓSTICA BRASIL LTDA 21/09/2026 Until 21/09/2036
Lactate Dehydrogenase2 (LDH2)
80146502431
III ABBOTT LABORATORIOS DO BRASIL LTDA 27/07/2026 Until 27/07/2036